Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Klebsiella pneumoniae infections in COVID-19 patients: a 2-month retrospective analysis in an Italian hospital
Gabriele Arcari, Giammarco Raponi, Federica Sacco, et al.
International Journal of Antimicrobial Agents (2020) Vol. 57, Iss. 1, pp. 106245-106245
Open Access | Times Cited: 55

Showing 1-25 of 55 citing articles:

Bacterial Coinfections in Coronavirus Disease 2019
Lars F. Westblade, Matthew S. Simon, Michael J. Satlin
Trends in Microbiology (2021) Vol. 29, Iss. 10, pp. 930-941
Open Access | Times Cited: 188
Coinfections with Other Respiratory Pathogens among Patients with COVID-19
K. Sreenath, Priyam Batra, E. V. Vinayaraj, et al.
Microbiology Spectrum (2021) Vol. 9, Iss. 1
Open Access | Times Cited: 122
Klebsiella pneumoniae induces host metabolic stress that promotes tolerance to pulmonary infection
Tania Wong Fok Lung, Daniel Charytonowicz, Kristin G. Beaumont, et al.
Cell Metabolism (2022) Vol. 34, Iss. 5, pp. 761-774.e9
Open Access | Times Cited: 61
SARS, MERS and CoVID-19
Manas Pustake, Isha Tambolkar, Purushottam Giri, et al.
Journal of Family Medicine and Primary Care (2022) Vol. 11, Iss. 1, pp. 10-17
Open Access | Times Cited: 53
Plasma cell-free RNA characteristics in COVID-19 patients
Yanqun Wang, Jie Li, Lu Zhang, et al.
Genome Research (2022) Vol. 32, Iss. 2, pp. 228-241
Open Access | Times Cited: 37
Gut microbiota from patients with COVID-19 cause alterations in mice that resemble post-COVID symptoms
Viviani Mendes de Almeida, Daiane F. Engel, Mayra Fernanda Ricci, et al.
Gut Microbes (2023) Vol. 15, Iss. 2
Open Access | Times Cited: 33
Carbapenem-Resistant Klebsiella pneumoniae Infections in ICU COVID-19 Patients—A Scoping Review
Wioletta Mędrzycka‐Dąbrowska, Sandra Lange, Katarzyna Zorena, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 10, pp. 2067-2067
Open Access | Times Cited: 51
Surging bloodstream infections and antimicrobial resistance during the first wave of COVID–19: a study in a large multihospital institution in the Paris region
Rishma Amarsy, D. Trystram, Emmanuelle Cambau, et al.
International Journal of Infectious Diseases (2021) Vol. 114, pp. 90-96
Open Access | Times Cited: 49
Prevalence of hypervirulent Klebsiella pneumoniae strains in COVID-19 patients with bacterial co-infections
Jingfen Zhang, Qiaoyu Li, Jingjing Liu, et al.
Frontiers in Microbiology (2025) Vol. 16
Open Access
Carbapenemase-producing Enterobacterales infections in COVID-19 patients
Vicente Pintado, Patricia Ruíz-Garbajosa, Rosa Escudero-Sánchez, et al.
Infectious Diseases (2021) Vol. 54, Iss. 1, pp. 36-45
Open Access | Times Cited: 28
The Collateral Effects of COVID-19 Pandemic on the Status of Carbapenemase-Producing Pathogens
Carole Ayoub Moubareck, Dalal Hammoudi Halat
Frontiers in Cellular and Infection Microbiology (2022) Vol. 12
Open Access | Times Cited: 19
Screening of Klebsiella pneumoniae subsp. pneumoniae Strains with Multi-Drug Resistance and Virulence Profiles Isolated from an Italian Hospital between 2020 and 2023
Valentina Dimartino, Carolina Venditti, Francesco Messina, et al.
Antibiotics (2024) Vol. 13, Iss. 6, pp. 561-561
Open Access | Times Cited: 3
Interplay between Klebsiella pneumoniae producing KPC-31 and KPC-3 under treatment with high dosage meropenem: a case report
Gabriele Arcari, Alessandra Oliva, Federica Sacco, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2022) Vol. 41, Iss. 3, pp. 495-500
Open Access | Times Cited: 15
Outbreak of ceftazidime-avibactam resistant Klebsiella pneumoniae carbapenemase (KPC)-producing Klebsiella pneumoniae in a COVID-19 intensive care unit, Italy: urgent need for updated diagnostic protocols of surveillance cultures
Gabriele Bianco, Matteo Boattini, Alessandro Bondi, et al.
Journal of Hospital Infection (2022) Vol. 122, pp. 217-219
Open Access | Times Cited: 15
Amikacin-loaded niosome nanoparticles improve amikacin activity against antibiotic-resistant Klebsiella pneumoniae strains
Mohamad Rahmati, Ebrahim Babapoor, Mehrouz Dezfulian
World Journal of Microbiology and Biotechnology (2022) Vol. 38, Iss. 12
Open Access | Times Cited: 15
A Comparative Study on Bacterial Co-Infections and Prevalence of Multidrug Resistant Organisms among Patients in COVID and Non-COVID Intensive Care Units.
Ravichandran Sathyakamala, R Alice Peace Selvabai, Priyadarshini Shanmugam
PubMed (2022) Vol. 63, Iss. 1, pp. E19-E26
Closed Access | Times Cited: 14
Problems Associated with Co-Infection by Multidrug-Resistant Klebsiella pneumoniae in COVID-19 Patients: A Review
Reham Yahya
Healthcare (2022) Vol. 10, Iss. 12, pp. 2412-2412
Open Access | Times Cited: 14
Carbapenem-Resistant Klebsiella pneumoniae in COVID-19 Era—Challenges and Solutions
Jozef Ficík, Michal Andrezál, Hana Drahovská, et al.
Antibiotics (2023) Vol. 12, Iss. 8, pp. 1285-1285
Open Access | Times Cited: 8
Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission
Alessandra Oliva, Giancarlo Ceccarelli, Cristian Borrazzo, et al.
Infection (2021) Vol. 49, Iss. 5, pp. 965-975
Open Access | Times Cited: 19
Global surveillance of antimicrobial resistance and hypervirulence in Klebsiella pneumoniae from LMICs: An in-silico approach
Reshma Silvester, A Madhavan, Aswin Kokkat, et al.
The Science of The Total Environment (2021) Vol. 802, pp. 149859-149859
Closed Access | Times Cited: 18
Impact of the COVID-19 Pandemic on the Prevalence of HAIs and the Use of Antibiotics in an Italian University Hospital
Giovanna Deiana, Antonella Arghittu, Davide Gentili, et al.
Healthcare (2022) Vol. 10, Iss. 9, pp. 1597-1597
Open Access | Times Cited: 12
Dexamethasone therapy and rates of secondary pulmonary and bloodstream infections in critically ill COVID-19 patients
Kathrin Rothe, Tobias Lahmer, Sebastian Rasch, et al.
Multidisciplinary Respiratory Medicine (2021) Vol. 16
Open Access | Times Cited: 17
Gut microbiota from patients with mild COVID-19 cause alterations in mice that resemble post-COVID syndrome
Viviani Mendes de Almeida, Daiane F. Engel, Mayra Fernanda Ricci, et al.
Research Square (Research Square) (2022)
Open Access | Times Cited: 11
Isolation of Carbapenem and Colistin Resistant Gram-Negative Bacteria Colonizing Immunocompromised SARS-CoV-2 Patients Admitted to Some Libyan Hospitals
Khouloud Slimene, Asrra A. Ali, Elhussan Ahmed Mohamed, et al.
Microbiology Spectrum (2023) Vol. 11, Iss. 3
Open Access | Times Cited: 6
Country-wide expansion of a VIM-1 carbapenemase-producing Klebsiella oxytoca ST145 lineage in Poland, 2009–2019
Marta Biedrzycka, Paweł Urbanowicz, Dorota Żabicka, et al.
European Journal of Clinical Microbiology & Infectious Diseases (2023) Vol. 42, Iss. 12, pp. 1449-1457
Open Access | Times Cited: 6
Page 1 - Next Page

Scroll to top